• GenFleet Therapeutics completed a private placement of 13,600,000 new H shares at HK$ 34.69 each on July 17, 2026.
• Gross proceeds totaled HK$ 471.8 million; net proceeds were about HK$ 466.9 million.
• New shares equal 3.87% of H shares; 3.54% of enlarged share capital.
• Total shares outstanding rose to 383,966,630, including 351,629,020 H shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genfleet Therapeutics (Shanghai) Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260717-12248532), on July 17, 2026, and is solely responsible for the information contained therein.